Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria

Abstract

Primarily responsible for the biogenesis and metabolism of biomolecules, endoplasmic reticulum (ER) and mitochondria are gradually becoming the targets of therapeutic modulation, whose physiological activities and pathological manifestations determine the functional capacity and even the survival of cells. Drug delivery systems with specific physicochemical properties (passive targeting), or modified by small molecular compounds, polypeptides, and biomembranes demonstrating tropism for ER and mitochondria (active targeting) are able to reduce the nonselective accumulation of drugs, enhancing efficacy while reducing side effects. Lipid nanoparticles feature high biocompatibility, diverse cargo loading, and flexible structure modification, which are frequently used for subcellular organelle‐targeted delivery of therapeutics. However, there is still a lack of systematic understanding of lipid nanoparticle‐based ER and mitochondria targeting. Herein, we review the pathological significance of drug selectively delivered to the ER and mitochondria. We also summarize the molecular basis and application prospects of lipid nanoparticle‐based ER and mitochondria targeting strategies, which may provide guidance for the prevention and treatment of associated diseases and disorders. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Biology‐Inspired Nanomaterials > Lipid‐Based Structures Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Diagnostic Tools > In Vivo Nanodiagnostics and Imaging

Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

“…ER-targeting small molecules specifically bind to the surface of the ER, accumulate, and disrupt ER function. 356 Sulfonamide ligands have been extensively developed for small molecule drugs and drug delivery vehicle modification due to its low toxicity, high efficiency, and high selectivity. 357 They specifically recognize and bind to sulfonylurea receptors with high affinity, which are potassium-selective ion channel proteins highly expressed on ER membranes.…”

Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer

“…For instance, biological selenium nanoparticles (SeNPs) can safeguard against intestinal barrier dysfunction by influencing endoplasmic reticulum stress (ERS) and mitochondrial autophagy-related AMPK signaling pathways. 174 Nano-drug delivery systems targeting mitochondria, nucleus, lysosomes, and Golgi have been investigated. 6 to kill cancer cells.…”

Bone regeneration strategies based on organelle homeostasis of mesenchymal stem cells

“…Unfortunately, due to ER's intricate structure, which includes a vast 3D interconnected network of various thicknesses, targeted navigation to the ER for therapeutic drugs is a tricky task (195). Currently, ER targeting strategies such as small molecules and metal complexes and ERtargeted peptides have provided key targets for cancer treatment (196). However, there has not yet been an application in MSCs.…”